Registry of the Patient Experience for Carpal Tunnel Release
Launched by SONEX HEALTH, INC. · Oct 4, 2023
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial, called the Registry of the Patient Experience for Carpal Tunnel Release, is studying the experiences of patients who are planning to have surgery for Carpal Tunnel Syndrome (CTS). The goal is to gather detailed information from a large group of patients about their experiences before and after the surgery. This will help researchers understand how well the surgery works and what patients go through during their recovery.
To participate, you need to be at least 18 years old and have been diagnosed with CTS in one or both hands. You should also have tried other treatments that didn't help. If you're chosen to join, you'll be asked to complete questionnaires about your health and recovery over the next two years. It's important to have a smartphone or email address to receive these questionnaires. The trial is currently looking for participants, and anyone interested should check if they meet the eligibility criteria. Your input could be valuable in improving treatment for others with this condition.
Gender
ALL
Eligibility criteria
- Inclusion Criteria 1. ≥18 years of age 2. Clinical diagnosis of unilateral or bilateral CTS 3. A clinical decision has been made to perform CTR on one or both hands 4. CTS-6 score ≥12 in the target hand(s)\* 5. Confirmatory diagnostic testing in the target hand(s)\*:
- • 1. CTR-US: Confirmatory diagnostic testing with ultrasound (median nerve cross-sectional area ≥10 mm2 in the proximal carpal tunnel region)
- • 2. ECTR or OCTR: Confirmatory electrodiagnostic testing 6. Prior failure of one or more nonsurgical treatment options (e.g., physical activity modification, bracing, splinting, corticosteroid injection) in the target hand(s) 7. Patient agrees to complete follow-up questionnaires over a 24-month period 8. Patient has a valid smart phone number and/or email address to receive and answer follow-up questionnaires
- • Note: An asterisk (\*) denotes that this criterion must be applied to the target hand for unilateral CTR procedures, or to both hands for simultaneous bilateral CTR procedures.
- Exclusion Criteria:
- • 1. Patient meets any of the contraindications per Instruction For Use (IFU)
- • 2. Patient has other medical, social, or psychological conditions that, in the opinion of the investigator, preclude them from completing all registry requirements.
About Sonex Health, Inc.
Sonex Health, Inc. is a pioneering clinical trial sponsor dedicated to advancing innovative medical solutions in the field of healthcare. With a focus on minimally invasive procedures, the company develops and conducts clinical trials aimed at improving patient outcomes and enhancing the quality of care. Leveraging cutting-edge technology and a commitment to rigorous scientific standards, Sonex Health collaborates with healthcare professionals and regulatory bodies to ensure the safety and efficacy of its treatments. Through its research efforts, Sonex Health strives to address unmet medical needs and deliver transformative solutions that improve the lives of patients globally.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Lexington, Kentucky, United States
Oklahoma City, Oklahoma, United States
Woburn, Massachusetts, United States
Gainesville, Florida, United States
Evansville, Indiana, United States
Aventura, Florida, United States
Miami Lakes, Florida, United States
Hyannis, Massachusetts, United States
Troy, Michigan, United States
Saint Louis, Missouri, United States
Las Vegas, Nevada, United States
Salem, New Hampshire, United States
Amherst, New York, United States
Conway, South Carolina, United States
Denton, Texas, United States
Jackson, Tennessee, United States
Raleigh, North Carolina, United States
Scottsdale, Arizona, United States
Lakeland, Florida, United States
Decatur, Illinois, United States
Tulsa, Oklahoma, United States
Fort Worth, Texas, United States
Madison, Wisconsin, United States
Scottsdale, Arizona, United States
Aventura, Florida, United States
Fort Walton Beach, Florida, United States
Gainesville, Florida, United States
Lakeland, Florida, United States
Miami Lakes, Florida, United States
Decatur, Illinois, United States
Evansville, Indiana, United States
Lexington, Kentucky, United States
Hyannis, Massachusetts, United States
Woburn, Massachusetts, United States
Troy, Michigan, United States
Saint Louis, Missouri, United States
Las Vegas, Nevada, United States
Albuquerque, New Mexico, United States
Amherst, New York, United States
Raleigh, North Carolina, United States
Oklahoma City, Oklahoma, United States
Tulsa, Oklahoma, United States
Bend, Oregon, United States
Conway, South Carolina, United States
Jackson, Tennessee, United States
Denton, Texas, United States
Fort Worth, Texas, United States
Madison, Wisconsin, United States
Foley, Alabama, United States
Melbourne, Florida, United States
Edina, Minnesota, United States
Jackson, Mississippi, United States
Eugene, Oregon, United States
Meadville, Pennsylvania, United States
East Providence, Rhode Island, United States
Salem, New Hampshire, United States
State College, Pennsylvania, United States
Glastonbury, Connecticut, United States
Miami, Florida, United States
Lebanon, New Hampshire, United States
Greenville, South Carolina, United States
Patients applied
Trial Officials
Victor M Marwin, MD, MBA
Principal Investigator
Bluegrass Orthopaedics
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported